p.mbeki
TL2 · Groningen
Contributes reviews on supplier material. Based in Groningen.
Joined 4 September 2025 · last posted 2d
72 posts, newest first. Showing up to 150.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #72 · Practice › Interactions · 26 Jul 2026 · 10 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Irish differences from the UK position — what changed since Replied, post #5 · Regional › UK & Ireland · 20 Jul 2026 · 0 likes Worth separating Irish differences as a question about the compound from Irish differences as a question about the documentation. They get answered by different people…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #97 · Compounds › Semaglutide · 9 Jul 2026 · 33 likes Where I have landed on semaglutide and gastric emptying, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Purity assay versus content assay: two different numbers Replied, post #10 · Analytics › COA interpretation · 30 Jun 2026 · 1 like Post #8 describes the usual case. This is about the unusual one. Water content by Karl Fischer is worth having on a lyophilised product because residual water is both a…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #25 · Compounds › Retatrutide · 29 Jun 2026 · 18 likes My position on retatrutide discussion is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Submitting a sample: the process end to end Replied, post #24 · Sourcing › Independent verification · 18 Jun 2026 · 4 likes On submitting a sample the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Racemisation and why it is invisible to a mass measurement Replied, post #16 · Analytics › Impurities & related substances · 9 Jun 2026 · 14 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Bioimpedance and hydration: why the number moves Replied, post #57 · Outcomes › Body composition · 8 Jun 2026 · 0 likes If you are new and reading this thread for the answer to bioimpedance and hydration: the answer is conditional, the conditions are in the third reply, and the rest of…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #20 · Evidence › Trials · 10 May 2026 · 0 likes Post #17 is right about the mechanism and I think understates the practical bit. What I can speak to on Primary endpoint hierarchies is narrow, so I will keep it narrow…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #43 · Meta › Announcements · 8 May 2026 · 1 like This follows post #42 rather than contradicting it. What I would want before treating Trust level 3 requirements as settled: the method, the sample, and whether anyone…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #6 · Sourcing › Independent verification · 23 Apr 2026 · 0 likes Careful with the language on Janoshik. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #35 · Outcomes › Body composition · 14 Apr 2026 · 11 likes Bioimpedance is considerably less precise and is strongly affected by hydration state, which is why readings move overnight without anything having changed.
-
CJC-1295 with and without DAC: what the modification does Replied, post #32 · Compounds › Secretagogues & GH axis · 12 Apr 2026 · 20 likes CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they have very different half-lives. Product descriptions frequently do…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #24 · Analytics › Impurities & related substances · 5 Apr 2026 · 0 likes Summarising the Residual solvents and scavengers thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction…
-
Grapefruit: why this class is not the class that cares Replied, post #117 · Practice › Interactions · 4 Apr 2026 · 15 likes My understanding of grapefruit is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Preprint servers and what screening they do Replied, post #87 · Evidence › Preprints · 13 Mar 2026 · 1 like A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. That…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #63 · Outcomes › Progress reports · 16 Feb 2026 · 0 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #100 · Clinical › Special populations · 13 Feb 2026 · 15 likes Having read the whole older adults thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #71 · Clinical › Bloodwork · 8 Feb 2026 · 8 likes Answering the question post #69 raises rather than the one it answers. Repeat before acting is standard practice for an isolated abnormal result on most analytes, and…
-
MHRA statements, read directly Replied, post #77 · Regional › UK & Ireland · 28 Jan 2026 · 1 like Building on post #76 rather than restating it. Cross-border movement between the two jurisdictions is not the same as domestic movement within either, and the rules are…
-
Request: export my own posts — one year on Replied, post #35 · Meta › Feature requests · 17 Jan 2026 · 6 likes Feature request I expect to be refused, stated anyway: a private notes field on a topic, visible only to me. I keep those in a text file and the text file loses the link.
-
Designing a personal experiment that could change your mind — one year on Replied, post #3 · Research Methods › N-of-1 designs · 17 Jan 2026 · 9 likes Coming back to the opening post, because the follow-up matters more than the original answer. Order effects matter. If you always try A before B, you cannot separate…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #82 · Practice › Side effects · 12 Jan 2026 · 20 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #13 · Practice › Administration · 9 Jan 2026 · 2 likes Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection into intact skin. Injecting before it dries is what stings.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #70 · Clinical › Special populations · 19 Dec 2025 · 9 likes What I would check first on Older adults is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Tracking a preprint to publication: a worked example Replied, post #100 · Evidence › Preprints · 10 Dec 2025 · 1 like Post #96 put the caveat in the right place and I want to underline it. If someone has run tracking a preprint properly I would rather read that than my own…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #16 · Compounds › Retatrutide · 28 Nov 2025 · 24 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #134 · Start Here › How to Ask · 23 Nov 2025 · 24 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #16 · Data & Tools › Calculators · 23 Nov 2025 · 13 likes Understood. Thank you for being specific about the limits of it.
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #64 · Pharmacology › Receptor biology · 10 Nov 2025 · 9 likes Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible explanation for differences between compounds in…
-
Dead volume across syringe and needle combinations Replied, post #20 · Devices › Syringes & needles · 5 Nov 2025 · 13 likes If your calculated volume is under two graduations, choose a lower concentration rather than trying to read between marks. Precision comes from the preparation, not the…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #6 · Compounds › Oral incretins · 3 Nov 2025 · 7 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
Amylin receptor signalling and satiety Replied, post #14 · Pharmacology › Receptor biology · 27 Oct 2025 · 1 like Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
-
A preprint whose numbers changed substantially at publication Replied, post #70 · Evidence › Preprints · 28 Sep 2025 · 0 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. I am aware this is the third time this month I have…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #60 · Practice › Reconstitution · 25 Sep 2025 · 13 likes I disagree with the framing of Over-dilution above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #126 · Access › Insurance & coverage · 19 Sep 2025 · 32 likes What I would want before treating Reading a denial letter as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #118 · Data & Tools › Calculators · 16 Sep 2025 · 0 likes A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #38 · Practice › Storage & stability · 29 Aug 2025 · 26 likes Taking post #35 at face value and following it one step further. The reason power cut for eleven hours keeps being re-asked is that the answer is conditional and people…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #40 · Start Here › How to Ask · 17 Aug 2025 · 31 likes Post #37 is the version of this I will quote in future. One addition. The specific question in the title is more useful than you might think. A title like "a question I…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #5 · Evidence › Preprints · 11 Aug 2025 · 0 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
Meeting a protein target on a suppressed appetite Replied, post #14 · Nutrition & Training › Protein & intake · 7 Aug 2025 · 6 likes Worth separating two things that post #12 runs together. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the…
-
How to research a compound with no human data without deceiving yourself Replied, post #110 · Compounds › Other compounds · 4 Aug 2025 · 0 likes An observation about research a compound that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
Lipase elevation without symptoms: the interpretation problem Replied, post #4 · Clinical › Bloodwork · 26 Jul 2025 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. Noting that I have skin in this question and have…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #132 · Compounds › Tirzepatide · 9 Jul 2025 · 27 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
-
Repeatability versus intermediate precision Replied, post #126 · Analytics › Method validation · 2 Jul 2025 · 1 like I read post #123 twice before replying, because I had assumed the opposite. My experience of repeatability versus intermediate precision contradicts the reply above. I…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #44 · Compounds › Semaglutide · 27 Jun 2025 · 2 likes Adding the measurement that post #43 says would settle it. On formulation: the licensed product is buffered and includes a preservative in the multi-dose presentation.…
-
Repeatability versus intermediate precision Replied, post #37 · Analytics › Method validation · 22 Jun 2025 · 22 likes Practical experience of repeatability versus intermediate precision, offered as one case with the conditions stated, not as a general finding. Conditions first, because…
-
Half-life, steady state, and accumulation worked through Replied, post #127 · Pharmacology › Pharmacokinetics · 16 Jun 2025 · 0 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #9 · Evidence › Journal club · 19 May 2025 · 26 likes Everything in post #7 holds. The case it does not cover is the one I have. Somebody should be asked to argue the paper's case even if nobody in the room believes it.…
-
A report I filed that turned out to be wrong, and the correction Replied, post #53 · Sourcing › Vendor reports · 14 May 2025 · 7 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Reading a chromatogram someone posted without axes Replied, post #30 · Analytics › HPLC & UHPLC · 8 May 2025 · 4 likes That is the distinction I keep failing to hold on to. Written down now.
-
A claim built entirely on a subgroup analysis Replied, post #23 · Evidence › Study critique · 7 May 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
Which panel is worth repeating and which is worth ignoring Replied, post #13 · Clinical › Bloodwork · 4 May 2025 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. I am aware this is the third time this month I have…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #17 · Practice › Dosing & titration · 12 Apr 2025 · 23 likes The most useful thing anyone has posted about holding a dose in this category was a table of what had been measured and by whom. That is what I would want again.
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #12 · Clinical › Bloodwork · 8 Apr 2025 · 5 likes Answering the question post #8 raises rather than the one it answers. Two sentences on hba1c lag and then I will stop, because the rest is speculation and the thread is…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #36 · Compounds › Secretagogues & GH axis · 3 Apr 2025 · 28 likes Post #35 answers the question as asked. The question underneath it is different. A note on scope: what I am saying about Tesamorelin applies to the case in the first…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #42 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 0 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
A page that has drifted out of date and needs a maintainer Replied, post #78 · Documentation › Wiki requests · 19 Mar 2025 · 0 likes Post #76 is right about the mechanism and I think understates the practical bit. A document with no maintainer becomes wrong quietly, which is worse than not existing,…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 14 Feb 2025 · 3 likes Worth distinguishing the combination product from the two components bought separately and mixed. Those are different pharmaceutical objects and nothing published about…
-
Revisiting: Aggregate verification data across the directory, with caveats Started this topic · Sourcing › Independent verification · 2 Feb 2025 · 29 likes Revisiting: Aggregate verification data across the directory, with caveats — setting out what I have, and where I think it stops being reliable. I have spent a…
-
Distinguishing a deletion sequence by mass alone Replied, post #6 · Analytics › Mass spectrometry · 20 Jan 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Follow-up: Individual participant data versus aggregate data Replied, post #86 · Evidence › Meta-analyses · 11 Jan 2025 · 15 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. Take it as a starting…
-
What changed in 2026, by region Replied, post #19 · Access › International · 12 Dec 2024 · 0 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position.
-
Revisiting: Moderation log format change Replied, post #52 · Meta › Announcements · 3 Dec 2024 · 32 likes Coming back to post #48, because the follow-up matters more than the original answer. Careful with the language on Moderation log format change. "Not detected" and "not…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #32 · Clinical › Special populations · 22 Nov 2024 · 24 likes Almost every population discussed here was excluded from the pivotal trials, which means the evidence base is observational at best and absent at worst. Speaking for…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #33 · Sourcing › Regulatory · 19 Nov 2024 · 11 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. I am not the right person to…
-
EMA product information as a primary source — does this still hold? Replied, post #37 · Regional › European Union · 15 Nov 2024 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Why "any advice?" is the least effective ending for a post Replied, post #37 · Start Here › How to Ask · 15 Nov 2024 · 17 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
About the International category Replied, post #10 · Access › International · 10 Oct 2024 · 6 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position. Noting that the question and the…
-
Progressive overload when the scale is falling — one year on Replied, post #115 · Nutrition & Training › Resistance training · 2 Oct 2024 · 6 likes Where I would push back on the Progressive overload consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Blind submission and why it changes minds Replied, post #14 · Sourcing › Independent verification · 13 Jul 2024 · 31 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. This has been discussed before and I could not…
-
Refrigerated versus room temperature: the trade-off stated plainly Replied, post #2 · Practice › Storage & stability · 29 Jun 2024 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…